Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are markers of systemic inflammation associated with poor outcome in several solid tumours. We retrospectively investigated the prognostic role of PLR and, secondly, NLR in mCRPC patients treated with Abiraterone Acetate (AA) or Enzalutamide (E), both in pre- and post-docetaxel setting.

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide

Pisano, Chiara
First
;
DI Stefano, Rosario F;Turco, Fabio;Samuelly, Alessandro;Bungaro, Maristella;Scagliotti, Giorgio V;DI Maio, Massimo;Buttigliero, Consuelo
Last
2021-01-01

Abstract

Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are markers of systemic inflammation associated with poor outcome in several solid tumours. We retrospectively investigated the prognostic role of PLR and, secondly, NLR in mCRPC patients treated with Abiraterone Acetate (AA) or Enzalutamide (E), both in pre- and post-docetaxel setting.
2021
1
10
Pisano, Chiara; Tucci, Marcello; DI Stefano, Rosario F; Turco, Fabio; Samuelly, Alessandro; Bungaro, Maristella; Vignani, Francesca; Tarenghi, Federica; Scagliotti, Giorgio V; DI Maio, Massimo; Buttigliero, Consuelo
File in questo prodotto:
File Dimensione Formato  
PLR_Paper_CP_25-06-20 preprint.docx

Accesso riservato

Tipo di file: PREPRINT (PRIMA BOZZA)
Dimensione 58.9 kB
Formato Microsoft Word XML
58.9 kB Microsoft Word XML   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1793547
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact